ƒCƒ“ƒeƒŠƒWƒFƒ“ƒgƒAƒŒ[ï’dm
u‰‰ŽžŠÔ ‰ïê •ó’Ë‘¢Œ`Œ|p‘åŠw ”~“cƒLƒƒƒ“ƒpƒX
                      Ÿ2003”N4ŒŽ2“ú(…)Ÿ

œX‰º@—³ˆêi‚à‚肵‚½@‚è‚イ‚¢‚¿j
@‘åã‘åŠw•‹³Žö ‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È
@ˆâ“`ŽqŽ¡—ÊwE‰Á—îˆãŠw
@ƒAƒ“ƒWƒFƒXMGiŠ”jŽæ’÷–ð

yu‰‰ƒe[ƒ}z
@ŠÖ¼‚ªƒoƒCƒI‚ÌŽñ“s‚Æ‚È‚é“ú
@`‘åŠw‚Ì’m‚ÌŽY‹Æ‰»‚ÉŒü‚¯‚ā`
uŽt—ª—ð ‚P‚X‚U‚Q”N ¶‚Ü‚ê
‚P‚X‚W‚V”N ‘åã‘åŠwˆãŠw•” ‘²‹Æ
‚P‚X‚X‚P”N ‘åã‘åŠwˆãŠw•” ˜V”N•auÀ‘åŠw‰@ ‘²‹Æ
ƒXƒ^ƒ“ƒtƒH[ƒh‘åŠw zŠÂŠí‰È Œ¤‹†ˆõ
‚P‚X‚X‚U”N ‘åã‘åŠwˆãŠw•” •Žè ˜V”N•aˆãŠw‹³Žº
‚P‚X‚X‚W”N ‘åã‘åŠwˆãŠw•” uŽt
‘åã‘åŠw•‹³Žö ‘åŠw‰@ˆãŠwŒnŒ¤‹†‰Èˆâ“`ŽqŽ¡—Êw
‘åã‘åŠw•‹³Žö ‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È‰Á—îˆãŠwiŒ“”Cj
ƒƒhƒW[ƒ“ƒoƒCƒIƒTƒCƒGƒ“ƒXŽÐ Ý—§
‚Q‚O‚O‚O”N

`‘åŠw ‹qˆõ‹³Žö
ƒƒhƒW[ƒ“ƒoƒCƒIƒTƒCƒGƒ“ƒXŽÐiŒ»AƒAƒ“ƒWƒFƒXMGŽÐjŽæ’÷–ðŒ“‹Æ

ŽóÜ—ð ‚P‚X‚X‚S”N ‘Û‚ŒŒˆ³Šw‰ïƒfƒ€ƒXŽáŽè§—ãÜ
‚P‚X‚X‚U”N •½¬8”N“x“ú–{zŠÂŠíŠw‰ïŽáŽèŒ¤‹†§—ãÜÅ—DGÜ
ƒAƒƒŠƒJ‚ŒŒˆ³•]‹c‰ïHarry GoldbrattÜ
‚P‚X‚X‚V”N ‘Û“®–¬d‰»Šw‰ïŽáŽè§—ãÜ
‚P‚X‚X‚W”N ‘æ‚V‚P‰ñ“ú–{“à•ª”åŠw‰ïŽáŽèŒ¤‹†§—ãÜ
‚P‚X‚X‚X”N “ú–{–ò—Šw‰ï‘æ‚P‚S‰ñŠwp§—ãÜ “ú–{ˆãŽt‰ïŒ¤‹†§—ãÜ
‚Q‚O‚O‚P”N “ú–{‚ŒŒˆ³Šw‰ïŽáŽèŒ¤‹†§—ãÜ
“ú–{SŒŒŠÇ“à•ª”åŠw‰ï‚•ô÷‹gŒ¤‹†§—ãÜ
‚Q‚O‚O‚Q”N “ú–{zŠÂŠíŠw‰ï²“¡Ü
Editorial
Board
‚P‚X‚X‚W”N` Circulation Research
‚P‚X‚X‚X”N` Circulation
Journal of Atherosclerosis and Thrombosis
‚Q‚O‚O‚O”N` Japanese Circulation Journal
Current Drug Targets
Current Gene Therapy
Heart
Journal of Hypertension
‘ΊOŠˆ“® ‚P‚X‚X‚X”N “ú–{ŒoÏV•· ŠÖ¼‚Q‚P¢‹Ií—ªˆÏˆõ‰ï ƒoƒCƒI¬ˆÏˆõ‰ïˆÏˆõ i`‚Q‚O‚O‚P”Nj
‚Q‚O‚O‚O”N ’m“IàŽYŒ¤‹†Šuˆã—Õª–ì‚É‚¨‚¯‚é @“Á‹–•ÛŒì‚Ì‚ ‚è•û‚ÉŠÖ‚·‚é’²¸Œ¤‹†vˆÏˆõ‰ïˆÏˆõi`‚Q‚O‚O‚P”Nj
‚Q‚O‚O‚P”N ‘åã¤H‰ï‹cŠuƒoƒCƒIî•ñƒnƒCƒEƒF[ŒŸ“¢‰ï‹cvÀ’· i`‚Q‚O‚O‚Q”Nj
ŒoÏŽY‹ÆÈ\‘¢‰üŠvR‹c‰ï ’m“IàŽY•”–åˆÏˆõ
“ú–{ŒoÏV•· “sŽsÄ¶ˆÏˆõ‰ïˆÏˆõ
‚Q‚O‚O‚Q”N •¶•”‰ÈŠwÈuŒ¤‹†—pŽ‘Œ¹‚ÌŽæ‚舵‚¢‚ÉŠÖ‚·‚錟“¢‰ï‹cvˆÏˆõ i`‚Q‚O‚O‚Q”Nj
ŠÖ¼ƒoƒCƒI„i‰ï‹cuŠÖ¼Œ—ƒ‰ƒCƒtƒTƒCƒGƒ“ƒX‚̍‘Û‹’“_Œ`¬ Šî–{\¬ŒŸ“¢‰ï‹cvÀ’·
“àŠt•{‘‡‰ÈŠw‹Zp‰ï‹cê–åˆÏˆõuŒ¤‹†ŠJ”­Œ^ƒxƒ“ƒ`ƒƒ[Žx‰‡v @@@‚Ù‚©

œŽóu¶‚̐º(“–“ú‚̃Aƒ“ƒP[ƒg‚æ‚è)

Eu‘å•Ï[ŽÀ‚µ‚½“à—e‚¾‚Á‚½vi46ÎE’j«j

Eu•·‚©‚¹‚Ä’¸‚¢‚Ä‚Æ‚Ä‚àŒ³‹C‚ªo‚Ü‚µ‚½vi42ÎE’j«j

EuƒoƒCƒI‚Ì•ª–삪•L‚¢Žsê‚ð•ø‚¦AˆßHZ‚Æ‚à–§Ú‚µ‚Ä‚¢‚邱‚Æ‚ð’m‚邱‚Æ‚ª‚Å‚«‚½vi33ÎE’j«j

Eu‚½‚¢‚Ö‚ñ—LˆÓ‹`‚ÈŽžŠÔ‚ð‰ß‚²‚¹‚½‚ÆŽv‚¢‚Ü‚·vi31ÎE’j«j